Enhancement of Bioavailability and Bioequivalence of Drug Delivery in Sensory Neural Hearing Loss

Bhatt Pr
{"title":"Enhancement of Bioavailability and Bioequivalence of Drug Delivery in Sensory Neural Hearing Loss","authors":"Bhatt Pr","doi":"10.23880/beba-16000215","DOIUrl":null,"url":null,"abstract":"Sensory neural hearing loss (SNHL) is a pervasive audiological disorder characterized by damage to the inner ear's hair cells or auditory nerve. Despite extensive research efforts, SNHL treatment remains a challenge due to various barriers, including limited drug penetration into the inner ear and the risk of systemic side effects. This abstract explores the innovative use of nanoparticles in intratympanic drug delivery as a promising solution to overcome these hurdles. Nanoparticles offer a unique platform for drug delivery to the inner ear, enhancing bioavailability and ensuring bioequivalence of therapeutic agents. Through targeted delivery, controlled release, and drug protection, nanoparticles address critical limitations in traditional SNHL treatments. These abstract reviews the barriers to SNHL treatment, the advantages of nanoparticle-based delivery systems, and their potential to revolutionize the management of SNHL. Further research in this field promises to unlock new opportunities for more effective and accessible treatments for SNHL patients","PeriodicalId":8995,"journal":{"name":"Bioequivalence & Bioavailability International Journal","volume":"30 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioequivalence & Bioavailability International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/beba-16000215","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Sensory neural hearing loss (SNHL) is a pervasive audiological disorder characterized by damage to the inner ear's hair cells or auditory nerve. Despite extensive research efforts, SNHL treatment remains a challenge due to various barriers, including limited drug penetration into the inner ear and the risk of systemic side effects. This abstract explores the innovative use of nanoparticles in intratympanic drug delivery as a promising solution to overcome these hurdles. Nanoparticles offer a unique platform for drug delivery to the inner ear, enhancing bioavailability and ensuring bioequivalence of therapeutic agents. Through targeted delivery, controlled release, and drug protection, nanoparticles address critical limitations in traditional SNHL treatments. These abstract reviews the barriers to SNHL treatment, the advantages of nanoparticle-based delivery systems, and their potential to revolutionize the management of SNHL. Further research in this field promises to unlock new opportunities for more effective and accessible treatments for SNHL patients
提高感觉神经性听力损失患者的生物利用度和给药的生物等效性
感觉神经性听力损失(SNHL)是一种普遍存在的听觉障碍,其特征是内耳毛细胞或听神经受损。尽管开展了大量的研究工作,但由于各种障碍,包括药物在内耳的渗透有限以及全身副作用的风险,SNHL 的治疗仍然是一项挑战。本摘要探讨了纳米颗粒在鼓室内给药中的创新应用,以此作为克服这些障碍的一种有希望的解决方案。纳米颗粒为内耳给药提供了一个独特的平台,可提高生物利用度并确保治疗药物的生物等效性。通过靶向给药、控制释放和药物保护,纳米颗粒解决了传统内耳道阻塞性硬化症治疗方法的关键局限性。本摘要回顾了SNHL治疗的障碍、基于纳米颗粒的给药系统的优势及其彻底改变SNHL治疗的潜力。该领域的进一步研究有望为 SNHL 患者带来更有效、更方便的治疗新机遇。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信